Ergomed plc (LON:ERGO – Get Rating) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 1,303.64 ($16.14) and traded as high as GBX 1,324 ($16.39). Ergomed shares last traded at GBX 1,314 ($16.27), with a volume of 25,663 shares.
Analyst Ratings Changes
A number of analysts have issued reports on the company. Shore Capital reaffirmed a “hold” rating on shares of Ergomed in a report on Thursday, December 8th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 1,450 ($17.95) price target on shares of Ergomed in a report on Tuesday, September 27th.
Ergomed Price Performance
The company has a market capitalization of £660.96 million and a PE ratio of 4,866.67. The company has a current ratio of 1.26, a quick ratio of 1.22 and a debt-to-equity ratio of 3.45. The stock has a fifty day simple moving average of GBX 1,303.64 and a 200-day simple moving average of GBX 1,212.44.
Insiders Place Their Bets
Ergomed Company Profile
Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance.
- Is the Northrop Grumman Selloff an Opportunity?
- Is the Worst Behind for Under Armor Stock with a New CEO?
- What Does Microsoft’s Investment in ChatGBT Mean for MSFT Stock?
- Analysts Like The Fit Of Skechers USA
- Can We Trust The Rally In The S&P 500
Receive News & Ratings for Ergomed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ergomed and related companies with MarketBeat.com's FREE daily email newsletter.